GHSD HD18 study: reducing chemotherapy toxicity in advanced stage Hodgkin lymphoma

Reducing Therapy-Related Toxicity in Hodgkin LymphomaПодробнее

Debate: Hodgkin lymphoma patient who remains PET+ at the end of chemotherapy - Radiation therapyПодробнее

What does the future hold for advanced stage Hodgkin's Lymphoma?Подробнее

Hodgkin's Lymphoma Survivor Story | More on Chemo Side Effects | The Patient StoryПодробнее

Improved treatment in advanced stage Hodgkin lymphoma through global clinical trialПодробнее

How I Manage Advanced Stage Hodgkin Lymphoma and What Do I Do at First RelapseПодробнее

How I Treat Hodgkin Lymphoma - Joseph Connors, MDПодробнее

Martin Hutchings, EHA 2018 – ECHELON-1 trial and chemotherapy regimens in Hodgkin’s lymphomaПодробнее

Joseph M. Connors, MD: Optimizing Therapy, Minimizing Toxicity in Hodgkin LymphomaПодробнее

How I Found out I had STAGE 4 Lymphoma!Подробнее

Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good resultsПодробнее

Nivolumab + chemotherapy in previously untreated stage III or IV Hodgkin lymphomaПодробнее

SWOG S1826 Study Design Discussion in Hodgkin's Lymphoma Patients #oncology #cancer #2023Подробнее

Initial Therapy of Advanced Stage Hodgkin Lymphoma: When to Use ABVD, A(BV)VD, and BEACOPPПодробнее

Addition of Targeted Drug Reduces Risk of First-Line Treatment Failure in Advanced Hodgkin LymphomaПодробнее

Brentuximab vedotin, nivolumab, doxorubicin & dacarbazine for early stage classical Hodgkin lymphomaПодробнее

Breakthrough Study for Advanced Stage Classic Hodgkin Lymphoma | ASCO 2023Подробнее

Advanced Hodgkin lymphoma, insights from the GHSG HD21 trialПодробнее

Dr. Diehl Compares US and EU Hodgkin Lymphoma StagingПодробнее